Drug Type Recombinant protein |
Synonyms rhPDGF and -beta-TCP |
Target |
Mechanism PDGFRβ agonists(Platelet-derived growth factor receptor beta agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alveolar Bone Loss | Phase 3 | IN | 01 Aug 2007 | |
Intrabony periodontal defect | Phase 3 | IN | 01 Aug 2007 |